MEDIFAST INC Balance Sheet
MED|13 years of annual SEC 10-K data (FY2011-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 13 fiscal years. All figures from audited SEC 10-K filings.
MEDIFAST INC had $248M in total assets and $199M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 4.08 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $89.3M | $90.9M | $94.4M | $163.7M | $77.0M | $75.1M | $42.0M | $24.5M | $36.4M | $39.9M | $14.3M | $17.2M | $10.6M |
| Accounts Receivable | - | - | - | $584.0K | $1.4M | $1.1M | $576.0K | $1.4M | $1.6M | $1.6M | $1.2M | $2.1M | $1.5M |
| Inventory | $20.2M | $42.4M | $54.6M | $53.4M | $48.8M | $20.2M | $19.3M | $18.3M | $13.3M | $15.7M | $18.1M | $20.8M | $20.0M |
| Current Assets | $201.7M | $214.4M | $224.0M | $234.3M | $154.2M | $145.5M | $125.2M | $101.3M | $88.1M | $81.9M | $92.0M | $88.6M | $64.0M |
| PP&E (Net) | $31.2M | $37.5M | $51.5M | $27.6M | $26.0M | $19.7M | $18.6M | $19.8M | $29.0M | $33.5M | $40.3M | $40.1M | $38.9M |
| Total Assets | $248.0M | $284.2M | $309.9M | $276.1M | $194.7M | $169.4M | $145.9M | $121.2M | $117.3M | $115.9M | $132.7M | $105.7M | $94.1M |
| Current Liabilities | $43.0M | $64.2M | $92.3M | $111.3M | $79.4M | $60.3M | $37.1M | $24.4M | $23.6M | $26.9M | $27.1M | $28.7M | $20.3M |
| Total Debt | - | - | - | - | - | - | - | - | - | - | - | $3.1M | $3.3M |
| Shareholders' Equity | $198.9M | $210.1M | $201.5M | $109.1M | $106.6M | $96.0M | $88.6M | $80.5M | $98.4M | $90.8M | $73.4M | $72.0M | $47.8M |